Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Photo of Martin D. Madaus
Individual Investor

Martin D. Madaus

Overview

Edit Overview Section
Number of Portfolio Companies 2
Number of Exits 
Unlock for free
  • Investor Type 
    obfuscation
  • Number of Exits 
    obfuscation

Personal Investments

Edit Personal Investments Section
Number of Investments 2
Martin D. Madaus has made 2 investments. Their latest investment was Seed Round - Osmoses on
obfuscation
, when Osmoses raised
obfuscation
.
Announced Date  
Organization Name  
Lead Investor  
Funding Round  
Money Raised  
obfuscation
Osmoses Logo
Osmoses
—
Seed Round - Osmoses Logo
Seed Round - Osmoses
obfuscation
obfuscation
Erbi Biosystems Logo
Erbi Biosystems
—
Venture Round - Erbi Biosystems Logo
Venture Round - Erbi Biosystems
obfuscation

Exits

Edit Exits Section
Number of Exits 
Unlock for free
Martin D. Madaus has
obfuscation
exit - Erbi Biosystems. Martin D. Madaus has
obfuscation
exits. Their most notable exits are Erbi Biosystems.
  • Erbi Biosystems Logo
    Erbi Biosystems Erbi Biosystems is a transformative microfluidic bioprocess instrumentation company.

Jobs

Edit Jobs Section
Number of Current Jobs 3
Number of Past Jobs 2
Martin D. Madaus has 3 current jobs including Chief Operating Officer at Sherlock Biosciences, Executive Chairman at Emulate, and Operating Executive at The Carlyle Group. Additionally, Martin D. Madaus has had 2 past jobs including Chairman & President & CEO at Millipore.
Organization Name  
Title At Company  
Start Date  
End Date  
Millipore Logo
Millipore
Chairman & President & CEOJan 2005Jul 2010
Roche Diagnostics Logo
Roche Diagnostics
President & CEO, North America20002004

Board and Advisor Roles

Edit Board and Advisor Roles Section
Number of Current Board & Advisor Roles 3
Martin D. Madaus holds 3 board and advisor roles including Advisor at Syncell, Board of Director at Ultivue, and Board Director at Quanterix.

Related Hubs

Edit Related Hubs Section
Hub Name  
CB Rank (Hub)  
Northeastern US Biotechnology Female Founded Acquired Companies Logo
Northeastern US Biotechnology Female Founded Acquired Companies
98,102
United States Health Diagnostics Acquired Companies Logo
United States Health Diagnostics Acquired Companies
34,629
Biotechnology Companies With Less Than $1B in Revenue (Top 10K) Logo
Biotechnology Companies With Less Than $1B in Revenue (Top 10K)
2,236
Biotechnology Companies that Exited Logo
Biotechnology Companies that Exited
2,506
New England Health Care Acquired Companies Logo
New England Health Care Acquired Companies
32,676
United States Acquired Companies With Less Than $1B in Revenue (Top 10K) Logo
United States Acquired Companies With Less Than $1B in Revenue (Top 10K)
505
United States Health Diagnostics Companies (Top 10K) Logo
United States Health Diagnostics Companies (Top 10K)
5,969
United States Life Science Companies Logo
United States Life Science Companies
10,624
United States Biotechnology Female Founded Companies Logo
United States Biotechnology Female Founded Companies
28,612
East Coast Acquired Companies With More Than 10 Employees (Top 10K) Logo
East Coast Acquired Companies With More Than 10 Employees (Top 10K)
762

Education

Edit Education Section
Martin D. Madaus studied at Ludwig Maximilian University of Munich.

Recent News and Activity

Edit Recent News and Activity Section
Funding Round•Oct 3, 2023
Osmoses raised
obfuscation
from Blindspot Ventures and 7 other investors
Discover more funding rounds
Funding Round•Jan 4, 2021
Erbi Biosystems raised
obfuscation
from Martin D. Madaus and Michael Chambers
Discover more funding rounds
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|